Filters

MEF2D Antibody

MEF2D Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameMEF2D Primary Polyclonal Antibody
Also known asMEF2D PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenMEF2D
SpecificityThis is a highly specific antibody against MEF2D
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human MEF2D
Gene ID number4209
Swiss ProtQ14814
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen 5'-YTA[AT](4)TAR-3', Mediates cellular functions not only in skeletal and cardiac muscle development, Plays a critical role in the regulation of neuronal apoptosis (By similarity), Plays diverse roles in the control of cell growth, but also in neuronal differentiation and survival, found in numerous muscle-specific, growth factor- and stress-induced genes, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription, Transcriptional activator which binds specifically to the MEF2 element
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names MEF2D, Myocyte-specific enhancer factor 2D
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetMEF2D
Short nameMEF2D Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative namemyocyte enhancer factor 2D (Antibody to)
Alternative techniqueantibodies
Alternative to gene target DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006366 and transcription from RNA polymerase II promoter and biological process this GO :0006915 and apoptotic process and biological process this GO :0007399 and nervous system development and biological process this GO :0007512 and adult heart development and biological process this GO :0007517 and muscle organ development and biological process this GO :0033613 and activating transcription factor binding and molecular function this GO :0035914 and skeletal muscle cell differentiation and biological process this GO :0042826 and histone deacetylase binding and molecular function this GO :0043231 and intracellular membrane-bounded organelle and cellular component this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046983 and protein dimerization activity and molecular function, MEF2D and IDBG-103519 and ENSG00000116604 and 4209, MEF2D and IDBG-631559 and ENSBTAG00000046545 and 100336730, Mef2d and IDBG-159892 and ENSMUSG00000001419 and 17261, nuclei, protein dimerization activity, this GO :0000977 and RNA polymerase II regulatory region sequence-specific DNA binding and molecular function this GO :0000981 and sequence-specific DNA binding RNA polymerase II transcription factor activity and molecular function this GO :0001649 and osteoblast differentiation and biological process this GO :0001958 and endochondral ossification and biological process this GO :0002062 and chondrocyte differentiation and biological process this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0006351 and transcription, this GO :0000977: RNA polymerase II regulatory region sequence-specific DNA binding, this GO :0000977: RNA polymerase II regulatory region sequence-specific DNA binding and also this GO :0000981: sequence-specific DNA binding RNA polymerase II transcription factor activity and also this GO :0003677: DNA binding and also this GO :0003700: sequence-specific DNA binding transcription factor activity and also this GO :0005515: protein binding and also this GO :0033613: activating transcription factor binding and also this GO :0042826: histone deacetylase binding and also this GO :0046983: protein dimerization activity, this GO :0000981: sequence-specific DNA binding RNA polymerase II transcription factor activity, this GO :0003677: DNA binding, this GO :0003700: sequence-specific DNA binding transcription factor activity, this GO :0005515: protein binding, this GO :0033613: activating transcription factor binding, this GO :0042826: histone deacetylase binding, this GO :0046983: protein dimerization activity, myocyte enhancer factor 2D
Identity 6997
Gene MEF2D
Long gene name myocyte enhancer factor 2D
Locus 1q22
Discovery year 1995-02-08
GenBank acession BC054520
Entrez gene record 4209
Pubmed identfication 8269842
RefSeq identity NM_005920
Classification Myocyte enhancer factor 2 proteins MADS box family
Havana BLAST/BLAT OTTHUMG00000033095

Subscribe to our Newsletter